A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes
Clinical trial NCT05607160 · COMPLETED
Trial details
- NCT number
- NCT05607160
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-05
- Primary completion
- 2023-12-11
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.